Revalia Bio

55 Church Street
Suite 400
New Haven, Connecticut 06510

Website: https://www.revaliabio.com

General Information:

Revalia Bio Inc. is launching a new category of pre-clinical research that gives drug developers early, predictive insights from real, functional human organs called ‘Human Data Trials’.

Despite billions spent on R&D each year, more than 90 percent of drug candidates fail to reach market approval. One of the key reasons is the poor translation from preclinical models to human biology. Animal models and in vitro systems often fall short in predicting how therapies will behave in real patients, leading to delays, cost overruns, and failed trials. Revalia is addressing this breakdown by delivering on-demand access to functional human data through its Human Data Trials — rigorous testing conducted on perfused, human organs maintained under clinical conditions.